105 related articles for article (PubMed ID: 36694315)
21. Construction of humanized CYP1A2 rats using CRISPR/Cas9 to promote drug metabolism and pharmacokinetic research.
Liu J; Lu J; Yao B; Zhang Y; Huang S; Chen X; Shen Y; Wang X
Drug Metab Dispos; 2023 Oct; ():. PubMed ID: 37884392
[TBL] [Abstract][Full Text] [Related]
22. Effects of alcohol on human carboxylesterase drug metabolism.
Parker RB; Hu ZY; Meibohm B; Laizure SC
Clin Pharmacokinet; 2015 Jun; 54(6):627-38. PubMed ID: 25511794
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of the inhibitory effects of antihypertensive drugs on human carboxylesterase in vitro.
Yanjiao X; Chengliang Z; Xiping L; Tao W; Xiuhua R; Dong L
Drug Metab Pharmacokinet; 2013; 28(6):468-74. PubMed ID: 23648675
[TBL] [Abstract][Full Text] [Related]
24. Development of a Caco-2 Cell Line Carrying the Human Intestine-Type CES Expression Profile as a Promising Tool for Ester-Containing Drug Permeability Studies.
Ishizaki Y; Furihata T; Oyama Y; Ohura K; Imai T; Hosokawa M; Akita H; Chiba K
Biol Pharm Bull; 2018; 41(5):697-706. PubMed ID: 29709907
[TBL] [Abstract][Full Text] [Related]
25. Creation of the 5-hydroxytryptamine receptor 7 knockout rat as a tool for cardiovascular research.
Demireva EY; Xie H; Flood ED; Thompson JM; Seitz BM; Watts SW
Physiol Genomics; 2019 Jul; 51(7):290-301. PubMed ID: 31125290
[TBL] [Abstract][Full Text] [Related]
26. Highly Efficient Genome Editing Using Geminivirus-Based CRISPR/Cas9 System in Cotton Plant.
Li B; Fu C; Zhou J; Hui F; Wang Q; Wang F; Wang G; Xu Z; Che L; Yuan D; Wang Y; Zhang X; Jin S
Cells; 2022 Sep; 11(18):. PubMed ID: 36139477
[TBL] [Abstract][Full Text] [Related]
27. Consequences of CRISPR-Cas9-Mediated CFTR Knockout in Human Macrophages.
Zhang S; Shrestha CL; Wisniewski BL; Pham H; Hou X; Li W; Dong Y; Kopp BT
Front Immunol; 2020; 11():1871. PubMed ID: 32973772
[TBL] [Abstract][Full Text] [Related]
28. A highly sensitive and selective enzyme activated fluorescent probe for in vivo profiling of carboxylesterase 2.
Liu SY; Zou X; Guo Y; Gao X
Anal Chim Acta; 2022 Aug; 1221():340126. PubMed ID: 35934362
[TBL] [Abstract][Full Text] [Related]
29. Determination and analysis of single nucleotide polymorphisms and haplotype structure of the human carboxylesterase 2 gene.
Wu MH; Chen P; Wu X; Liu W; Strom S; Das S; Cook EH; Rosner GL; Dolan ME
Pharmacogenetics; 2004 Sep; 14(9):595-605. PubMed ID: 15475733
[TBL] [Abstract][Full Text] [Related]
30. CRISPR-Cas9: A method for establishing rat models of drug metabolism and pharmacokinetics.
Lu J; Liu J; Guo Y; Zhang Y; Xu Y; Wang X
Acta Pharm Sin B; 2021 Oct; 11(10):2973-2982. PubMed ID: 34745851
[TBL] [Abstract][Full Text] [Related]
31. Comparison of gene editing efficiencies of CRISPR/Cas9 and TALEN for generation of MSTN knock-out cashmere goats.
Zhang J; Liu J; Yang W; Cui M; Dai B; Dong Y; Yang J; Zhang X; Liu D; Liang H; Cang M
Theriogenology; 2019 Jul; 132():1-11. PubMed ID: 30981084
[TBL] [Abstract][Full Text] [Related]
32. Characterization of organic anion transporting polypeptide 1b2 knockout rats generated by CRISPR/Cas9: a novel model for drug transport and hyperbilirubinemia disease.
Ma X; Shang X; Qin X; Lu J; Liu M; Wang X
Acta Pharm Sin B; 2020 May; 10(5):850-860. PubMed ID: 32528832
[TBL] [Abstract][Full Text] [Related]
33. Generation of Acsl4 Gene Knockout Mouse Model by CRISPR/Cas9-Mediated Genome Engineering.
Ren H; Hua Z; Meng J; Molenaar A; Bi Y; Cheng N; Zheng X
Crit Rev Biomed Eng; 2019; 47(5):419-426. PubMed ID: 32422031
[TBL] [Abstract][Full Text] [Related]
34. The pharmacogenetics of carboxylesterases: CES1 and CES2 genetic variants and their clinical effect.
Merali Z; Ross S; Paré G
Drug Metabol Drug Interact; 2014; 29(3):143-51. PubMed ID: 24988246
[TBL] [Abstract][Full Text] [Related]
35. Ontogenic expression of human carboxylesterase-2 and cytochrome P450 3A4 in liver and duodenum: postnatal surge and organ-dependent regulation.
Chen YT; Trzoss L; Yang D; Yan B
Toxicology; 2015 Apr; 330():55-61. PubMed ID: 25724353
[TBL] [Abstract][Full Text] [Related]
36. Efficient generation of Knock-in/Knock-out marmoset embryo via CRISPR/Cas9 gene editing.
Kumita W; Sato K; Suzuki Y; Kurotaki Y; Harada T; Zhou Y; Kishi N; Sato K; Aiba A; Sakakibara Y; Feng G; Okano H; Sasaki E
Sci Rep; 2019 Sep; 9(1):12719. PubMed ID: 31481684
[TBL] [Abstract][Full Text] [Related]
37. Characterization and Proteomic-Transcriptomic Investigation of Monocarboxylate Transporter 6 Knockout Mice: Evidence of a Potential Role in Glucose and Lipid Metabolism.
Jones RS; Tu C; Zhang M; Qu J; Morris ME
Mol Pharmacol; 2019 Sep; 96(3):364-376. PubMed ID: 31436537
[TBL] [Abstract][Full Text] [Related]
38. Human carboxylesterase-2 hydrolyzes the prodrug of gemcitabine (LY2334737) and confers prodrug sensitivity to cancer cells.
Pratt SE; Durland-Busbice S; Shepard RL; Heinz-Taheny K; Iversen PW; Dantzig AH
Clin Cancer Res; 2013 Mar; 19(5):1159-68. PubMed ID: 23325581
[TBL] [Abstract][Full Text] [Related]
39. CRISPR/Cas9 generated human CD46, CD55 and CD59 knockout cell lines as a tool for complement research.
Thielen AJF; van Baarsen IM; Jongsma ML; Zeerleder S; Spaapen RM; Wouters D
J Immunol Methods; 2018 May; 456():15-22. PubMed ID: 29447841
[TBL] [Abstract][Full Text] [Related]
40. Elucidation of metabolic pathways of 25-hydroxyvitamin D3 mediated by CYP24A1 and CYP3A using Cyp24a1 knockout rats generated by CRISPR/Cas9 system.
Yasuda K; Nishikawa M; Okamoto K; Horibe K; Mano H; Yamaguchi M; Okon R; Nakagawa K; Tsugawa N; Okano T; Kawagoe F; Kittaka A; Ikushiro S; Sakaki T
J Biol Chem; 2021; 296():100668. PubMed ID: 33865853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
